🔎 Trials Near Me

Početna › Akutna limfoblastna leukemija › Minnesota

Kliničke studije za Akutna limfoblastna leukemija u državi Minnesota

14 studija za Akutna limfoblastna leukemija traži sudionike na lokacijama u državi Minnesota.

Gradovi u državi Minnesota

Službeni tekst studije (engleski)

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

  • Riverwood Healthcare Center, Aitkin
  • Mayo Clinic Health System in Albert Lea, Albert Lea
  • Essentia Health - Baxter Clinic, Baxter
  • i još 48
U tijeku regrutacijaOpažajna studijaZdravi dobrovoljci dobrodošli
Od 40 do 75 godina · Oba spola · Ažurirano 2. lis 2026. · NCT05334069

The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study

  • Children's Hospitals and Clinics of Minnesota - Minneapolis, Minneapolis
  • University of Minnesota/Masonic Cancer Center, Minneapolis
  • Mayo Clinic in Rochester, Rochester
U tijeku regrutacijaFaza 1/2
Do 22 godina · Oba spola · Ažurirano 25. kol 2026. · NCT04726241

Caloric Restriction and Activity to Reduce Chemoresistance in B-ALL

  • Children's Hospitals and Clinics of Minnesota, Minneapolis
U tijeku regrutacijaFaza 2
Od 7 do 25 godina · Oba spola · Ažurirano 19. kol 2026. · NCT05082519

A Study of CTD402 in T-ALL/LBL Patients

  • Mayo Clinic - Rochester, Rochester
U tijeku regrutacijaFaza 1/2
Od 1 godina i više · Oba spola · Ažurirano 19. kol 2026. · NCT07070219

Allo HSCT Using RIC and PTCy for Hematological Diseases

  • Masonic Cancer Center at University of Minnesota, Minneapolis
U tijeku regrutacijaFaza 2
Do 75 godina · Oba spola · Ažurirano 6. srp 2026. · NCT05805605

Myeloablative Allo HSCT With Related or Unrelated Donor for Heme Disorders

  • Masonic Cancer Center at University of Minnesota, Minneapolis
U tijeku regrutacijaFaza 2
Do 60 godina · Oba spola · Ažurirano 25. lip 2026. · NCT03314974

TINI 2: Total Therapy for Infants With Acute Lymphoblastic Leukemia II

  • Children's Hospital of Minnesota, Minneapolis
U tijeku regrutacijaFaza 1/2
Do 1 godina · Oba spola · Ažurirano 3. lip 2026. · NCT05848687

Backtracking Leukemia-Typical Somatic Mutations in Cord Blood

  • University of Minnesota/Masonic Cancer Center, Minneapolis
U tijeku regrutacijaOpažajna studija
Do 25 godina · Oba spola · Ažurirano 8. tra 2026. · NCT05014165

MT2021-08T Cell Receptor Alpha/Beta Depletion PBSC Transplantation for Heme Malignancies

  • University of Minnesota Masonic Cancer Center, Minneapolis
U tijeku regrutacijaFaza 2
Do 60 godina · Oba spola · Ažurirano 6. tra 2026. · NCT05735717

Exploring the Effect of Calaspargase Pegol on the Coagulation System in Pediatric Acute Lymphoblastic Leukemia (ALL) Patients: Pilot Study

  • Mayo Clinic in Rochester, Rochester
U tijeku regrutacijaOpažajna studija
Od 2 do 22 godina · Oba spola · Ažurirano 13. velj 2026. · NCT07071051

Fitness and Lung Function Among Survivors of Heart Transplant, Leukemia and Infant BPD Through Exercise

  • Masonic Cancer Center, Minneapolis
U tijeku regrutacijaOpažajna studija
Od 8 do 25 godina · Oba spola · Ažurirano 24. stu 2025. · NCT05025774

Auto Stem Cell Transplant for Lymphoma Patients

  • Masonic Cancer Center, University of Minnesota, Minneapolis
U tijeku regrutacijaFaza 2
Do 75 godina · Oba spola · Ažurirano 4. stu 2025. · NCT03125642

Prevention of GvHD in Participants With Hematological Malignancies Undergoing Hematopoietic Stem Cell Transplant (HSCT)

  • University of Minnesota, Minneapolis
U tijeku regrutacijaFaza 1
Od 18 godina i više · Oba spola · Ažurirano 15. tra 2025. · NCT06462365

Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies

  • Children's Hospital and Clinics of Minnesota, Minneapolis
U tijeku regrutacijaFaza 1
Od 1 do 21 godina · Oba spola · Ažurirano 6. pro 2024. · NCT05476770

Iz ClinicalTrials.gov, podaci preuzeti 5. lis 2026.. Svaka studija ima svoje uvjete prihoda; tim studije odlučuje tko se može priključiti.